These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12730801)

  • 1. Optimizing bone metabolism in osteoporosis: insight into the pharmacologic profile of strontium ranelate.
    Marie PJ
    Osteoporos Int; 2003; 14 Suppl 3():S9-12. PubMed ID: 12730801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strontium ranelate: a novel mode of action optimizing bone formation and resorption.
    Marie PJ
    Osteoporos Int; 2005 Jan; 16 Suppl 1():S7-10. PubMed ID: 15578159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strontium ranelate in osteoporosis.
    Reginster JY
    Curr Pharm Des; 2002; 8(21):1907-16. PubMed ID: 12171530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation.
    Marie PJ
    Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S11-5. PubMed ID: 16735840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strontium ranelate: a physiological approach for optimizing bone formation and resorption.
    Marie PJ
    Bone; 2006 Feb; 38(2 Suppl 1):S10-4. PubMed ID: 16439191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Strontium ranelate: a novel concept for the treatment of osteoporosis].
    Dimai HP
    Wien Klin Wochenschr; 2005 Nov; 117(21-22):728-38. PubMed ID: 16416353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in bone strength parameters. The role of strontium ranelate.
    Tournis S
    J Musculoskelet Neuronal Interact; 2007; 7(3):266-7. PubMed ID: 17947810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strontium ranelate: a new paradigm in the treatment of osteoporosis.
    Reginster JY; Deroisy R; Jupsin I
    Drugs Today (Barc); 2003 Feb; 39(2):89-101. PubMed ID: 12698204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats.
    Marie PJ; Hott M; Modrowski D; De Pollak C; Guillemain J; Deloffre P; Tsouderos Y
    J Bone Miner Res; 1993 May; 8(5):607-15. PubMed ID: 8511988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone.
    Farlay D; Boivin G; Panczer G; Lalande A; Meunier PJ
    J Bone Miner Res; 2005 Sep; 20(9):1569-78. PubMed ID: 16059629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mineralization of bone tissue: a forgotten dimension in osteoporosis research.
    Boivin G; Meunier PJ
    Osteoporos Int; 2003; 14 Suppl 3():S19-24. PubMed ID: 12730799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro.
    Bonnelye E; Chabadel A; Saltel F; Jurdic P
    Bone; 2008 Jan; 42(1):129-38. PubMed ID: 17945546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats.
    Ammann P; Shen V; Robin B; Mauras Y; Bonjour JP; Rizzoli R
    J Bone Miner Res; 2004 Dec; 19(12):2012-20. PubMed ID: 15537445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strontium ranelate treatment enhances hydroxyapatite-coated titanium screws fixation in osteoporotic rats.
    Li Y; Feng G; Gao Y; Luo E; Liu X; Hu J
    J Orthop Res; 2010 May; 28(5):578-82. PubMed ID: 20014319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Strontium ranelate's (Osseor) dual mode of action: increasing bone mass and decreasing bone resorption].
    Kaliterna DM
    Reumatizam; 2008; 55(2):73-4. PubMed ID: 19024281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment with strontium ranelate increases vertebral bone mass without deleterious effect in mice.
    Delannoy P; Bazot D; Marie PJ
    Metabolism; 2002 Jul; 51(7):906-11. PubMed ID: 12077740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive therapy in osteoporosis using a single drug: from ADFR to strontium ranelate.
    Manette C; Collette J; Sarlet N; Tancredi A; Zegels B; Reginster JY
    Curr Med Chem; 2006; 13(13):1585-90. PubMed ID: 16787205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strontium ranelate: a novel mode of action leading to renewed bone quality.
    Ammann P
    Osteoporos Int; 2005 Jan; 16 Suppl 1():S11-5. PubMed ID: 15578157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strontium as therapy for osteoporosis.
    Marie PJ
    Curr Opin Pharmacol; 2005 Dec; 5(6):633-6. PubMed ID: 16183330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strontium ranelate promotes osteoblastic differentiation and mineralization of murine bone marrow stromal cells: involvement of prostaglandins.
    Choudhary S; Halbout P; Alander C; Raisz L; Pilbeam C
    J Bone Miner Res; 2007 Jul; 22(7):1002-10. PubMed ID: 17371157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.